In silico mutagenesis: decreasing the immunogenicity of botulinum toxin type A

References

• Ansari, H. R., & Raghava, G. P. (2010). Identification of conformational B-cell epitopes in an antigen from its primary sequence. Immunome Research, 6(1), 6–9. doi:10.1186/1745-7580-6-6
   PubMedGoogle Scholar
• Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22(2), 195–201. doi:10.1093/bioinformatics/bti770
   PubMed Web of Science ®Google Scholar
• Babiloni, A. H., Kapos, F. P., & Nixdorf, D. R. (2016). Intraoral administration of botulinum toxin for trigeminal neuropathic pain. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 121(6), e148–e153. doi:10.1016/j.oooo.2016.03.013
   PubMed Web of Science ®Google Scholar
• Bazmara, H., Rasooli, I., Jahangiri, A., Sefid, F., Astaneh, S. D. A., & Payandeh, Z. (2017). Antigenic properties of iron regulated proteins in Acinetobacter baumannii: An in silico approach. International Journal of Peptide Research and Therapeutics, 1–9 [published online]. doi:10.1007/s10989-017-9665-6
   Web of Science ®Google Scholar
• Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics, 27(3), 343–350. doi:10.1093/bioinformatics/btq662
   PubMed Web of Science ®Google Scholar
• Benkert, P., Tosatto, S. C., & Schomburg, D. (2008). QMEAN: A comprehensive scoring function for model quality assessment. Proteins: Structure, Function, and Bioinformatics, 71(1), 261–277. doi:10.1002/prot.21715
   PubMed Web of Science ®Google Scholar
• Bentivoglio, A. R., Del Grande, A., Petracca, M., Ialongo, T., & Ricciardi, L. (2015). Clinical differences between botulinum neurotoxin type A and B. Toxicon, 107, 77–84. doi:10.1016/j.toxicon.2015.08.001
   PubMed Web of Science ®Google Scholar
• Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., … Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research, 42(W1), W252–W258. doi:10.1093/nar/gku340
   PubMed Web of Science ®Google Scholar
• Bowie, J. U., Lüthy, R., & Eisenberg, D. (1991). A method to identify protein sequences that fold into a known three-dimensional structure. Science, 253(5016), 164–170. doi:10.1126/science.1853201
   PubMed Web of Science ®Google Scholar
• Brooks, V. B. (1954). The action of botulinum toxin on motor‐nerve filaments. The Journal of Physiology, 123(3), 501–515. doi:10.1113/jphysiol.1954.sp005067
   PubMed Web of Science ®Google Scholar
• Capriotti, E., Fariselli, P., & Casadio, R. (2005). I-Mutant2. 0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research, 33(Web Server), W306–W310. doi:10.1093/nar/gki375
   PubMed Web of Science ®Google Scholar
• Careta, M. F., Delgado, L., & Patriota, R. (2015). Report of allergic reaction after application of botulinum toxin. Aesthetic Surgery Journal, 35(5), NP102–NP105. doi:10.1093/asj/sju105
   PubMed Web of Science ®Google Scholar
• Carruthers, A., & Carruthers, J. (2005). Botulinum toxin type A. Journal of the American Academy of Dermatology, 53(2), 284–290. doi:10.1016/j.jaad.2005.03.060
   PubMed Web of Science ®Google Scholar
• Castelao, M., Marques, R. E., Duarte, G. S., Rodrigues, F. B., Ferreira, J., Sampaio, C., … Costa, J. (2017). Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews, 12, CD003633. doi:10.1002/14651858.CD003633.pub3.
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519. doi:10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(4), 1–7. doi:10.1186/1471-2105-8-4
   PubMedGoogle Scholar
• Dressler, D. (2016). Botulinum toxin drugs: Brief history and outlook. Journal of Neural Transmission, 123(3), 277–279. doi:10.1007/s00702-015-1478-1
   PubMed Web of Science ®Google Scholar
• Dressler, D., & Bigalke, H. (2017). Immunological aspects of botulinum toxin therapy. Expert Review of Neurotherapeutics, 17(5), 487–494. doi:10.1080/14737175.2017.1262258
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology, 277, 396–404. doi:10.1016/S0076-6879(97)77022-8
   PubMed Web of Science ®Google Scholar
• Emini, E. A., Hughes, J. V., Perlow, D., & Boger, J. (1985). Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. Journal of Virology, 55(3), 836–839.
   PubMed Web of Science ®Google Scholar
• Fattahian, Y., Riahi-Madvar, A., Mirzaee, R., Asadikaram, G., & Rahbar, M. R. (2017). In silico locating the immune-reactive segments of Lepidium draba peroxidase and designing a less immune-reactive enzyme derivative. Computational Biology and Chemistry, 70, 21–30. doi:10.1016/j.compbiolchem.2017.07.003
   PubMed Web of Science ®Google Scholar
• Fonfria, E., Elliott, M., Beard, M., Chaddock, J., & Krupp, J. (2018). Engineering botulinum toxins to improve and expand targeting and SNARE cleavage activity. Toxins, 10(7), 278. doi:10.3390/toxins10070278
   Web of Science ®Google Scholar
• Frevert, J. (2015). Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products. Drugs in R&D, 15(1), 1–9. doi:10.1007/s40268-014-0077-1
   PubMed Web of Science ®Google Scholar
• Gasteiger, E., Hoogland, C., Gattiker, A., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005). Protein identification and analysis tools on the ExPASy server. In: Walker, J. M. (Ed.), The proteomics protocols handbook (pp. 571–607). New York, NY: Humana press. doi:10.1385/1-59259-890-0:571
   Google Scholar
• Hajighahramani, N., Nezafat, N., Eslami, M., Negahdaripour, M., Rahmatabadi, S. S., & Ghasemi, Y. (2017). Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus. Infection, Genetics and Evolution, 48, 83–94. doi: 10.1016/j.meegid.2016.12.010
   PubMed Web of Science ®Google Scholar
• Henriques, J., Cragnell, C., & Skepö, M. (2015). Molecular dynamics simulations of intrinsically disordered proteins: Force field evaluation and comparison with experiment. Journal of Chemical Theory and Computation, 11(7), 3420–3431. doi:10.1021/ct501178z
   PubMed Web of Science ®Google Scholar
• Hill, K. K., Xie, G., Foley, B. T., & Smith, T. J. (2015). Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins. Toxicon, 107, 2–8. doi:10.1016/j.toxicon.2015.09.011
   PubMed Web of Science ®Google Scholar
• Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., & Gelpí, J. L. (2012). MDWeb and MDMoby: An integrated web-based platform for molecular dynamics simulations. Bioinformatics, 28(9), 1278–1279. doi:10.1093/bioinformatics/bts139
   PubMed Web of Science ®Google Scholar
• Ikai, A. (1980). Thermostability and aliphatic index of globular proteins. The Journal of Biochemistry, 88(6), 1895–1898. doi:10.1093/oxfordjournals.jbchem.a133168
   Web of Science ®Google Scholar
• Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017). BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research, 45(W1), W24–W29. doi:10.1093/nar/gkx346
   PubMed Web of Science ®Google Scholar
• Kalyanaraman, N. (2018). In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1. Molecular Immunology, 93, 193–205. doi:10.1016/j.molimm.2017.11.024
   PubMed Web of Science ®Google Scholar
• Kamaraj, B., & Purohit, R. (2013). In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3. BioMed Research International, 2013, 1 (article ID 697051). doi:10.1155/2013/697051
   Web of Science ®Google Scholar
• Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. (2015). The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols, 10(6), 845–858. doi:10.1038/nprot.2015.053
   PubMed Web of Science ®Google Scholar
• Kolaskar, A. S., & Tongaonkar, P. C. (1990). A semi‐empirical method for prediction of antigenic determinants on protein antigens. FEBS Letters, 276(1-2), 172–174. doi:10.1016/0014-5793(90)80535-Q
   PubMed Web of Science ®Google Scholar
• Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Computational Biology, 8(12), e1002829. doi:10.1371/journal.pcbi.1002829
   PubMed Web of Science ®Google Scholar
• Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., & Stevens, R. C. (1998). Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nature Structural Biology, 5(10), 898–902. doi:10.1038/2338
   PubMedGoogle Scholar
• Larsen, J. E. P., Lund, O., & Nielsen, M. (2006). Improved method for predicting linear B-cell epitopes. Immunome Research, 2(1), 2–7. doi:10.1186/1745-7580-2-2
   PubMedGoogle Scholar
• Lewitt, P. A., & Trosch, R. M. (1997). Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection. Movement Disorders, 12(6), 1064–1067. doi:10.1002/mds.870120637
   PubMed Web of Science ®Google Scholar
• Li, M., Goldberger, B. A., & Hopkins, C. (2005). Fatal case of BOTOX®-related anaphylaxis? Journal of Forensic Sciences, 50(1), 169–172. doi:10.1520/JFS2004196
   Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83. doi:10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Luvisetto, S., Gazerani, P., Cianchetti, C., & Pavone, F. (2015). Botulinum toxin type A as a therapeutic agent against headache and related disorders. Toxins, 7(9), 3818–3844. doi:10.3390/toxins7093818
   PubMed Web of Science ®Google Scholar
• Moon, I. J., Chang, S. E., & Kim, S. D. (2017). First case of anaphylaxis after botulinum toxin type A injection. Clinical and Experimental Dermatology, 42(7), 760–762. doi:10.1111/ced.13108
   PubMed Web of Science ®Google Scholar
• Negahdaripour, M., Eslami, M., Nezafat, N., Hajighahramani, N., Ghoshoon, M. B., Shoolian, E., … Ghasemi, Y. (2017). A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches. Infection, Genetics and Evolution, 54, 402–416. doi:10.1016/j.meegid.2017.08.002
   PubMed Web of Science ®Google Scholar
• Nezafat, N., Karimi, Z., Eslami, M., Mohkam, M., Zandian, S., & Ghasemi, Y. (2016). Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction-based approaches. Computational Biology and Chemistry, 62, 82–95. doi:10.1016/j.compbiolchem.2016.04.006
   PubMed Web of Science ®Google Scholar
• Pahil, S., Taneja, N., Ansari, H. R., & Raghava, G. P. S. (2017). In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. PloS One, 12(8), e0180505. doi:10.1371/journal.pone.0180505
   PubMed Web of Science ®Google Scholar
• Potocnakova, L., Bhide, M., & Pulzova, L. B. (2016). An introduction to B-cell epitope mapping and in silico epitope prediction. Journal of Immunology Research, 2016(6760830), 1–11. doi:10.1155/2016/6760830
   Google Scholar
• Rajendran, V., & Sethumadhavan, R. (2014). Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, 32(2), 209–221. doi:10.1080/07391102.2012.759885
   PubMed Web of Science ®Google Scholar
• Rigoni, M., Caccin, P., Johnson, E. A., Montecucco, C., & Rossetto, O. (2001). Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A. Biochemical and Biophysical Research Communications, 288(5), 1231–1237. doi:10.1006/bbrc.2001.5911
   PubMed Web of Science ®Google Scholar
• Rosenfield, L. K., Kardassakis, D. G., Tsia, K. A., & Stayner, G. (2014). The first case report of a systemic allergy to OnabotulinumtoxinA (Botox) in a healthy patient. Aesthetic Surgery Journal, 34(5), 766–768. doi:10.1177/1090820X14532648
   PubMed Web of Science ®Google Scholar
• Saha, S., & Raghava, G. P. S. (2006). Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network. Proteins: Structure, Function, and Bioinformatics, 65(1), 40–48. doi:10.1002/prot.21078
   PubMed Web of Science ®Google Scholar
• Schellekens, H. (2002). Immunogenicity of therapeutic proteins: Clinical implications and future prospects. Clinical Therapeutics, 24(11), 1720–1740. doi:10.1016/S0149-2918(02)80075-3
   PubMed Web of Science ®Google Scholar
• Scott, A. B. (1981). Botulinum toxin injection of eye muscles to correct strabismus. Transactions of the American Ophthalmological Society, 79, 734–770.
   PubMedGoogle Scholar
• Sefid, F., Rasooli, I., Jahangiri, A., & Bazmara, H. (2015). Functional exposed amino acids of BauA as potential immunogen against Acinetobacter baumannii. Acta Biotheoretica, 63(2), 129–149. doi:10.1007/s10441-015-9251-2
   PubMed Web of Science ®Google Scholar
• Shi, J., Zhang, J., Li, S., Sun, J., Teng, Y., Wu, M., … Hu, Y. (2015). Epitope-based vaccine target screening against highly pathogenic MERS-CoV: An in silico approach applied to emerging infectious diseases. PloS One, 10(12), e0144475. doi:10.1371/journal.pone.0144475
   PubMed Web of Science ®Google Scholar
• Silvaggi, N. R., Boldt, G. E., Hixon, M. S., Kennedy, J. P., Tzipori, S., Janda, K. D., & Allen, K. N. (2007). Structures of Clostridium botulinum neurotoxin serotype A light chain complexed with small-molecule inhibitors highlight active-site flexibility. Chemistry & Biology, 14(5), 533–542. doi:10.1016/j.chembiol.2007.03.014
   PubMed Web of Science ®Google Scholar
• Singh, H., Ansari, H. R., & Raghava, G. P. (2013). Improved method for linear B-cell epitope prediction using antigen’s primary sequence. PloS One, 8(5), e62216. doi:10.1371/journal.pone.0062216
   PubMed Web of Science ®Google Scholar
• Swearingen, K. E., Lindner, S. E., Shi, L., Shears, M. J., Harupa, A., Hopp, C. S., … Sinnis, P. (2016). Interrogating the Plasmodium sporozoite surface: Identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathogens, 12(4), e1005606. doi:10.1371/journal.ppat.1005606
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server), W407–W410. doi:10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Yao, B., Zhang, L., Liang, S., & Zhang, C. (2012). SVMTriP: A method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity. PloS One, 7(9), e45152. doi:10.1371/journal.pone.0045152
   PubMed Web of Science ®Google Scholar
• Yasmin, T., Akter, S., Debnath, M., Ebihara, A., Nakagawa, T., & Nabi, A. N. (2016). In silico proposition to predict cluster of B-and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni. In Silico Pharmacology, 4(5), 1–10. doi:10.1186/s40203-016-0020-y
   PubMedGoogle Scholar
• Zarei, M., Nezafat, N., Rahbar, M. R., Negahdaripour, M., Sabetian, S., Morowvat, M. H., & Ghasemi, Y. (2018). Decreasing the immunogenicity of arginine deiminase enzyme via structure‐based computational analysis. Journal of Biomolecular Structure and Dynamics, 1–14 [published online]. doi:10.1080/07391102.2018.1431151
   Web of Science ®Google Scholar